QUOTE AND NEWS
Cloud Computing  Jul 23  Comment 
through the adoption of Varonis DatAnywhere. read more
Bloomberg  Jul 13  Comment 
Aberdeen Sees Consumer Spending Boom in Indonesian Roads A two-hour drive from Jakarta, near a tea plantation developed by the Dutch, 48-year-old Atmi makes about $250 a month...
DailyFinance  Mar 15  Comment 
Law Offices of Howard G. Smith announces that it is investigating potential claims against the Board of Directors of ATMI, Inc. (“ATMI” or the “Company”) (NASDAQ:ATMI) related to the proposed acquisition of the Company...
DailyFinance  Mar 10  Comment 
Rigrodsky & Long, P.A. announces a complaint alleging breaches of fiduciary duty and other violations of law has been filed in Connecticut Superior Court, Danbury Judicial District against the board of directors of...
DailyFinance  Feb 26  Comment 
NEW YORK, NY -- (Marketwired) -- 02/26/14 -- Levi & Korsinsky notifies investors of ATMI, Inc. ("ATMI" or "the Company") (NASDAQ: ATMI) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of...
DailyFinance  Feb 14  Comment 
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of ATMI, Inc. (NasdaqGS:ATMI) (“ATMI”) in connection with the sale of the Company to Entegris, Inc. (NasdaqGS:ENTG). ...
SeekingAlpha  Feb 5  Comment 
Complete Story »
StreetInsider.com  Feb 4  Comment 
* ntegris, Inc. (Nasdaq: ENTG) and ATMI (Nasdaq: ATMI) announced that the Boards of Directors of both companies have unanimously approved a definitive merger agreement under which Entegris will acquire ATMI for a total equity value of...
Benzinga  Feb 4  Comment 
Zynga (NASDAQ: ZNGA) shares touched a new 52-week high of $4.84 after UBS upgraded the stock from Neutral to Buy and lifted the price target from $4.00 to $6.00. Furiex Pharmaceuticals (NASDAQ: FURX) shares jumped 148.56% to reach a new 52-week...
StreetInsider.com  Feb 4  Comment 
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) 132.3% HIGHER; announced top-line results indicating the company’s two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki